CLINICAL_TRIALS
trial_result
· 2021-11-22
Clinical Trial Update: Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [Phase 3]
Summary
Phase 3 trial comparing pyronaridine-artesunate 3:1 granules to crushed Coartem tablets in pediatric Plasmodium falciparum malaria; study completed with posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2021-11-22